C2C Development: Detailed Company Information & Corporate Profile

Contact top employees from C2C Development

Summary

The business currently specializes in Medical Devices area. The company has 1-10 employees. Register with SignalHire to connect with C2C Development employees and management.

C2C Development Websitec2c-dev.com
Social Links
linkedIn
Phone Number+1 321 728 0125
Industries
Company Size1-10 employees
SpecialtiesMedical Device, Intellectual Property Strategy, Product Development, Process Development, Regulatory Affairs, Quality Assurance, Technology Leveraging
Founded2007
Estimated Annual Revenue$1 - 10M
Updated:2026-08-13

Competitors

Name
Founded
Type
Employees
2015Privately
Held
25 - 100
2014Privately
Held
100-200
1995Privately
Held
10-50
-Privately
Held
10-50

Workforce Turnover

Length of Employment

arrow

C2C Development's workforce includes employees across a wide range of tenure levels.

100% have been with the company for 8 to 10 years
Contact top employees from C2C Development
Unlock contacts
Dillon Nobles
Dillon NoblesEngineer Intern
Unlock contacts

C2C Development Corporate Information: FAQ

C2C Development operates in the Medtech industries. More details can be found on the official website: c2c-dev.com.
C2C Development has offices located in US.
The headquarters of C2C Development are located in United States.
You can contact C2C Development by phone at +1 321 728 0125.
C2C Development currently employs 1-10 people.
Well-known competitors of C2C Development include Pyrexar Medical, Astura Medical, Apical Instruments and Able Medical Devices.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP